- Home
- PHIO vs INBS Comparison
PHIO vs INBS Comparison
Compare PHIO & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- INBS
- Stock Information
- Founded
- PHIO 2011
- INBS 2016
- Country
- PHIO United States
- INBS United States
- Employees
- PHIO N/A
- INBS N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- PHIO Health Care
- INBS Health Care
- Exchange
- PHIO Nasdaq
- INBS Nasdaq
- Market Cap
- PHIO 8.6M
- INBS 8.7M
- IPO Year
- PHIO N/A
- INBS N/A
- Fundamental
- Price
- PHIO $2.00
- INBS $1.41
- Analyst Decision
- PHIO Strong Buy
- INBS
- Analyst Count
- PHIO 1
- INBS 0
- Target Price
- PHIO $4.00
- INBS N/A
- AVG Volume (30 Days)
- PHIO 875.3K
- INBS 127.7K
- Earning Date
- PHIO 05-15-2025
- INBS 05-13-2025
- Dividend Yield
- PHIO N/A
- INBS N/A
- EPS Growth
- PHIO N/A
- INBS N/A
- EPS
- PHIO N/A
- INBS N/A
- Revenue
- PHIO N/A
- INBS $2,936,472.00
- Revenue This Year
- PHIO N/A
- INBS $280.88
- Revenue Next Year
- PHIO N/A
- INBS $126.26
- P/E Ratio
- PHIO N/A
- INBS N/A
- Revenue Growth
- PHIO N/A
- INBS 3.87
- 52 Week Low
- PHIO $0.97
- INBS $1.00
- 52 Week High
- PHIO $9.79
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- PHIO 54.98
- INBS 54.99
- Support Level
- PHIO $1.71
- INBS $1.18
- Resistance Level
- PHIO $2.08
- INBS $1.57
- Average True Range (ATR)
- PHIO 0.13
- INBS 0.11
- MACD
- PHIO 0.01
- INBS 0.03
- Stochastic Oscillator
- PHIO 76.32
- INBS 60.98
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).